Cleveland BioLabs Inc
CBLI
Get informed when a big investor buys or sells
+ FollowMarket Cap$226.39M
Close$
$3.54
11.7% upside
Current Fair Value
11.7% upsideUndervalued by 11.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $226.39 Million |
|---|---|
| Enterprise Value | $212.61 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.19 |
| Beta | 0.68 |
| Outstanding Shares | 15,478,945 |
Return
| Return on Equity | -30.78% |
|---|---|
| Return on Assets | -19.07% |
| Return on Invested Capital | -20.48% |
Valuation & Multiples
| P/E Ratio | -16.38 |
|---|---|
| PEG | -20.92 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4871.39 |
| Enterprise Value to EBIT | -76.74 |
| Enterprise Value to Net Income | -81 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data